Sargent Bickham Lagudis’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $4.23M | Buy |
|
|||||
|
2022
Q3 | $3.53M | Buy |
|
|||||
|
2022
Q2 | $3.23M | Sell |
|
|||||
|
2022
Q1 | $3.16M | Buy |
|
|||||
|
2021
Q4 | $2.7M | Buy |
|
|||||
|
2021
Q3 | $277K | Buy |
|
|||||
|
2021
Q2 | $204K | Buy |
|
|||||
|
2021
Q1 | $143K | Buy |
|
|||||
|
2020
Q4 | $115K | Buy |
|
|||||
|
2020
Q3 | $98K | Hold |
|
|||||
|
2020
Q2 | $109K | Hold |
|
|||||
|
2020
Q1 | $92K | Sell |
|
|||||
|
2019
Q4 | $116K | Buy |
|
|||||
|
2019
Q3 | $74K | Buy |
|
|||||
|
2019
Q2 | $54K | Buy |
|
|||||
|
2019
Q1 | $63K | Sell |
|
|||||
|
2018
Q4 | $71K | Sell |
|
|||||
|
2018
Q3 | $98K | Buy |
|
|||||
|
2018
Q2 | $78K | Sell |
|
|||||
|
2018
Q1 | $82K | Sell |
|
|||||
|
2017
Q4 | $112K | Buy |
|
|||||
|
2017
Q3 | $102K | Buy |
|
|||||
|
2017
Q2 | $49K | Buy |
|
|||||
|
2017
Q1 | $44K | Hold |
|
|||||
|
2016
Q4 | $39K | Hold |
|
|||||
|
2016
Q3 | $42 | Sell |
|
|||||
|
2016
Q2 | $69K | Hold |
|
|||||
|
2016
Q1 | $63K | Buy |
|